Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...

Novo Nordisk A/S’s failure to meet its own bar for success on a next-generation obesity shot shows the danger of promising ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Illustration: Elizabeth Smelov Novo Nordisk’s big bet to improve on the success of its weight-loss drug franchise hit a ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

Nestle is launching protein shots in the United States, the latest effort by the world's biggest packaged food maker to tap ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

The food and beverage giant is once again addressing the growing popularity of weight-loss drugs with a protein shot designed ...